nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC4—Nateglinide—type 2 diabetes mellitus	0.147	0.279	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0841	0.16	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.075	0.143	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Metformin—type 2 diabetes mellitus	0.0738	0.14	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0638	0.121	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0431	0.0819	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Losartan—type 2 diabetes mellitus	0.0394	0.0749	CbGbCtD
Adefovir Dipivoxil—NME2—islet of Langerhans—type 2 diabetes mellitus	0.00341	0.0474	CbGeAlD
Adefovir Dipivoxil—NME1—Paromomycin—Acarbose—type 2 diabetes mellitus	0.00326	0.623	CbGdCrCtD
Adefovir Dipivoxil—AK2—cortex of kidney—type 2 diabetes mellitus	0.00325	0.0452	CbGeAlD
Adefovir Dipivoxil—AK2—adipose tissue—type 2 diabetes mellitus	0.00301	0.0418	CbGeAlD
Adefovir Dipivoxil—AK4—retina—type 2 diabetes mellitus	0.00298	0.0414	CbGeAlD
Adefovir Dipivoxil—NME2—retina—type 2 diabetes mellitus	0.00291	0.0405	CbGeAlD
Adefovir Dipivoxil—AK4—nephron tubule—type 2 diabetes mellitus	0.00281	0.039	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—liver—type 2 diabetes mellitus	0.00278	0.0387	CbGeAlD
Adefovir Dipivoxil—NME1—cardiovascular system—type 2 diabetes mellitus	0.00262	0.0364	CbGeAlD
Adefovir Dipivoxil—NME1—kidney—type 2 diabetes mellitus	0.00256	0.0356	CbGeAlD
Adefovir Dipivoxil—AK4—cardiovascular system—type 2 diabetes mellitus	0.00252	0.0351	CbGeAlD
Adefovir Dipivoxil—AK4—kidney—type 2 diabetes mellitus	0.00247	0.0343	CbGeAlD
Adefovir Dipivoxil—NME2—cardiovascular system—type 2 diabetes mellitus	0.00247	0.0343	CbGeAlD
Adefovir Dipivoxil—AK4—cortex of kidney—type 2 diabetes mellitus	0.0024	0.0334	CbGeAlD
Adefovir Dipivoxil—NME2—pancreas—type 2 diabetes mellitus	0.0024	0.0333	CbGeAlD
Adefovir Dipivoxil—NME1—adipose tissue—type 2 diabetes mellitus	0.00231	0.0321	CbGeAlD
Adefovir Dipivoxil—AK4—adipose tissue—type 2 diabetes mellitus	0.00222	0.0309	CbGeAlD
Adefovir Dipivoxil—NME2—adipose tissue—type 2 diabetes mellitus	0.00217	0.0302	CbGeAlD
Adefovir Dipivoxil—AK2—liver—type 2 diabetes mellitus	0.00211	0.0293	CbGeAlD
Adefovir Dipivoxil—NME1—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00198	0.377	CbGdCrCtD
Adefovir Dipivoxil—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00183	0.0255	CbGeAlD
Adefovir Dipivoxil—Tenofovir—ABCC2—type 2 diabetes mellitus	0.00183	0.6	CrCbGaD
Adefovir Dipivoxil—ABCC5—retina—type 2 diabetes mellitus	0.00169	0.0235	CbGeAlD
Adefovir Dipivoxil—NME1—liver—type 2 diabetes mellitus	0.00162	0.0225	CbGeAlD
Adefovir Dipivoxil—ABCC5—nephron tubule—type 2 diabetes mellitus	0.00159	0.0222	CbGeAlD
Adefovir Dipivoxil—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00157	0.0218	CbGeAlD
Adefovir Dipivoxil—AK4—liver—type 2 diabetes mellitus	0.00156	0.0217	CbGeAlD
Adefovir Dipivoxil—NME2—liver—type 2 diabetes mellitus	0.00152	0.0212	CbGeAlD
Adefovir Dipivoxil—ABCC5—adipose tissue—type 2 diabetes mellitus	0.00126	0.0175	CbGeAlD
Adefovir Dipivoxil—Tenofovir—CYP1A2—type 2 diabetes mellitus	0.00122	0.4	CrCbGaD
Adefovir Dipivoxil—ABCC4—nephron tubule—type 2 diabetes mellitus	0.00111	0.0154	CbGeAlD
Adefovir Dipivoxil—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.0011	0.0152	CbGeAlD
Adefovir Dipivoxil—SLC22A3—kidney—type 2 diabetes mellitus	0.001	0.0139	CbGeAlD
Adefovir Dipivoxil—ABCC4—kidney—type 2 diabetes mellitus	0.000971	0.0135	CbGeAlD
Adefovir Dipivoxil—ABCC4—pancreas—type 2 diabetes mellitus	0.000965	0.0134	CbGeAlD
Adefovir Dipivoxil—SLC22A8—kidney—type 2 diabetes mellitus	0.000964	0.0134	CbGeAlD
Adefovir Dipivoxil—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000946	0.0131	CbGeAlD
Adefovir Dipivoxil—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000939	0.013	CbGeAlD
Adefovir Dipivoxil—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000903	0.0125	CbGeAlD
Adefovir Dipivoxil—ABCC5—liver—type 2 diabetes mellitus	0.000886	0.0123	CbGeAlD
Adefovir Dipivoxil—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000875	0.0122	CbGeAlD
Adefovir Dipivoxil—SLC22A3—liver—type 2 diabetes mellitus	0.000633	0.0088	CbGeAlD
Adefovir Dipivoxil—ABCC4—liver—type 2 diabetes mellitus	0.000614	0.00853	CbGeAlD
Adefovir Dipivoxil—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000367	0.00142	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000363	0.00141	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000363	0.00141	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000362	0.0014	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Valsartan—type 2 diabetes mellitus	0.000362	0.0014	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00036	0.0014	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.00036	0.00139	CcSEcCtD
Adefovir Dipivoxil—Rash—Repaglinide—type 2 diabetes mellitus	0.00036	0.00139	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000359	0.00139	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000359	0.00139	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000358	0.00139	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000358	0.00139	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Orlistat—type 2 diabetes mellitus	0.000357	0.00139	CcSEcCtD
Adefovir Dipivoxil—Headache—Repaglinide—type 2 diabetes mellitus	0.000357	0.00138	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Losartan—type 2 diabetes mellitus	0.000356	0.00138	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000356	0.00138	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000356	0.00138	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000356	0.00138	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000355	0.00138	CcSEcCtD
Adefovir Dipivoxil—Back pain—Valsartan—type 2 diabetes mellitus	0.000355	0.00138	CcSEcCtD
Adefovir Dipivoxil—Back pain—Orlistat—type 2 diabetes mellitus	0.000351	0.00136	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00035	0.00136	CcSEcCtD
Adefovir Dipivoxil—Cough—Gliclazide—type 2 diabetes mellitus	0.000349	0.00135	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000348	0.00135	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00134	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Glyburide—type 2 diabetes mellitus	0.000346	0.00134	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000345	0.00134	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000343	0.00133	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Losartan—type 2 diabetes mellitus	0.000341	0.00132	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00034	0.00132	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00034	0.00132	CcSEcCtD
Adefovir Dipivoxil—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00034	0.00132	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00034	0.00132	CcSEcCtD
Adefovir Dipivoxil—Nausea—Repaglinide—type 2 diabetes mellitus	0.000339	0.00131	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Glipizide—type 2 diabetes mellitus	0.000338	0.00131	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000338	0.00131	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000338	0.00131	CcSEcCtD
Adefovir Dipivoxil—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000338	0.00131	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Metformin—type 2 diabetes mellitus	0.000334	0.0013	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Glipizide—type 2 diabetes mellitus	0.000334	0.00129	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000331	0.00128	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Metformin—type 2 diabetes mellitus	0.000329	0.00128	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000325	0.00126	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000324	0.00126	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000323	0.00125	CcSEcCtD
Adefovir Dipivoxil—Cough—Valsartan—type 2 diabetes mellitus	0.00032	0.00124	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Ramipril—type 2 diabetes mellitus	0.00032	0.00124	CcSEcCtD
Adefovir Dipivoxil—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00032	0.00124	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00032	0.00124	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00032	0.00124	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000319	0.00124	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Ramipril—type 2 diabetes mellitus	0.000317	0.00123	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000317	0.00123	CcSEcCtD
Adefovir Dipivoxil—Cough—Orlistat—type 2 diabetes mellitus	0.000316	0.00123	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000316	0.00122	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000316	0.00122	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000315	0.00122	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000315	0.00122	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00122	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00122	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000313	0.00121	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Valsartan—type 2 diabetes mellitus	0.000312	0.00121	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Valsartan—type 2 diabetes mellitus	0.000312	0.00121	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000311	0.00121	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000311	0.0012	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00031	0.0012	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000309	0.0012	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Orlistat—type 2 diabetes mellitus	0.000309	0.0012	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Orlistat—type 2 diabetes mellitus	0.000309	0.0012	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000308	0.00119	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000307	0.00119	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000306	0.00118	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000301	0.00117	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0003	0.00116	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Glipizide—type 2 diabetes mellitus	0.0003	0.00116	CcSEcCtD
Adefovir Dipivoxil—Rash—Glipizide—type 2 diabetes mellitus	0.000297	0.00115	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000297	0.00115	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000297	0.00115	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000297	0.00115	CcSEcCtD
Adefovir Dipivoxil—Headache—Glipizide—type 2 diabetes mellitus	0.000296	0.00115	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000294	0.00114	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000293	0.00114	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Losartan—type 2 diabetes mellitus	0.000293	0.00113	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000292	0.00113	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000292	0.00113	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000291	0.00113	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00029	0.00112	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000288	0.00111	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000287	0.00111	CcSEcCtD
Adefovir Dipivoxil—Back pain—Losartan—type 2 diabetes mellitus	0.000287	0.00111	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000287	0.00111	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000287	0.00111	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Valsartan—type 2 diabetes mellitus	0.000286	0.00111	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000285	0.0011	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Metformin—type 2 diabetes mellitus	0.000285	0.0011	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Metformin—type 2 diabetes mellitus	0.000285	0.0011	CcSEcCtD
Adefovir Dipivoxil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000283	0.0011	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000283	0.0011	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000281	0.00109	CcSEcCtD
Adefovir Dipivoxil—Nausea—Glipizide—type 2 diabetes mellitus	0.00028	0.00109	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00028	0.00108	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00108	CcSEcCtD
Adefovir Dipivoxil—Rash—Glimepiride—type 2 diabetes mellitus	0.000278	0.00108	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000277	0.00107	CcSEcCtD
Adefovir Dipivoxil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00107	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00107	CcSEcCtD
Adefovir Dipivoxil—Headache—Glimepiride—type 2 diabetes mellitus	0.000276	0.00107	CcSEcCtD
Adefovir Dipivoxil—Cough—Irbesartan—type 2 diabetes mellitus	0.000275	0.00107	CcSEcCtD
Adefovir Dipivoxil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000275	0.00107	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Losartan—type 2 diabetes mellitus	0.000274	0.00106	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000273	0.00106	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00105	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00027	0.00105	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000269	0.00104	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000269	0.00104	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000268	0.00104	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000267	0.00104	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000267	0.00103	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000267	0.00103	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Metformin—type 2 diabetes mellitus	0.000265	0.00103	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000264	0.00102	CcSEcCtD
Adefovir Dipivoxil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000262	0.00101	CcSEcCtD
Adefovir Dipivoxil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000261	0.00101	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000261	0.00101	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Glyburide—type 2 diabetes mellitus	0.000261	0.00101	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00026	0.00101	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Metformin—type 2 diabetes mellitus	0.00026	0.00101	CcSEcCtD
Adefovir Dipivoxil—Cough—Losartan—type 2 diabetes mellitus	0.000259	0.001	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000259	0.001	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000258	0.000999	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000258	0.000999	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000257	0.000997	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000257	0.000996	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000256	0.00099	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000255	0.000986	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Losartan—type 2 diabetes mellitus	0.000253	0.000979	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Losartan—type 2 diabetes mellitus	0.000253	0.000979	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000253	0.000979	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000252	0.000978	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000252	0.000977	CcSEcCtD
Adefovir Dipivoxil—Rash—Bromocriptine—type 2 diabetes mellitus	0.00025	0.000971	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00097	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00025	0.000969	CcSEcCtD
Adefovir Dipivoxil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000249	0.000964	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000249	0.000963	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000248	0.000963	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000245	0.000951	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000245	0.000949	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000242	0.000938	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00024	0.000931	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000238	0.000921	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000237	0.000919	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000237	0.000919	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000237	0.000918	CcSEcCtD
Adefovir Dipivoxil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000236	0.000914	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000236	0.000913	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000235	0.000909	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000234	0.000907	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000234	0.000907	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000234	0.000907	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Losartan—type 2 diabetes mellitus	0.000231	0.000895	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000231	0.000895	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000231	0.000894	CcSEcCtD
Adefovir Dipivoxil—Rash—Glyburide—type 2 diabetes mellitus	0.000229	0.000887	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000229	0.000886	CcSEcCtD
Adefovir Dipivoxil—Headache—Glyburide—type 2 diabetes mellitus	0.000227	0.000882	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000227	0.000878	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000224	0.000867	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000223	0.000865	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000223	0.000864	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000222	0.000861	CcSEcCtD
Adefovir Dipivoxil—Cough—Ramipril—type 2 diabetes mellitus	0.000222	0.000861	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000221	0.000855	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Ramipril—type 2 diabetes mellitus	0.000217	0.00084	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Ramipril—type 2 diabetes mellitus	0.000217	0.00084	CcSEcCtD
Adefovir Dipivoxil—Nausea—Glyburide—type 2 diabetes mellitus	0.000216	0.000836	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000216	0.000836	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000215	0.000834	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Valsartan—type 2 diabetes mellitus	0.000215	0.000833	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000213	0.000826	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Orlistat—type 2 diabetes mellitus	0.000212	0.000823	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000212	0.000821	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000211	0.000816	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000211	0.000816	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Orlistat—type 2 diabetes mellitus	0.000209	0.000812	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000207	0.000803	CcSEcCtD
Adefovir Dipivoxil—Rash—Gliclazide—type 2 diabetes mellitus	0.000206	0.000797	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000205	0.000796	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000205	0.000794	CcSEcCtD
Adefovir Dipivoxil—Headache—Gliclazide—type 2 diabetes mellitus	0.000204	0.000792	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000204	0.00079	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000203	0.000789	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000203	0.000789	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000203	0.000788	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000203	0.000785	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000202	0.000782	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000198	0.000768	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Ramipril—type 2 diabetes mellitus	0.000198	0.000767	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Metformin—type 2 diabetes mellitus	0.000196	0.000759	CcSEcCtD
Adefovir Dipivoxil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000194	0.000751	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Metformin—type 2 diabetes mellitus	0.000193	0.000748	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000192	0.000742	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000192	0.000742	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Valsartan—type 2 diabetes mellitus	0.00019	0.000738	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000189	0.000733	CcSEcCtD
Adefovir Dipivoxil—Rash—Valsartan—type 2 diabetes mellitus	0.000189	0.000732	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000189	0.000731	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000188	0.000729	CcSEcCtD
Adefovir Dipivoxil—Headache—Valsartan—type 2 diabetes mellitus	0.000188	0.000727	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000187	0.000723	CcSEcCtD
Adefovir Dipivoxil—Rash—Orlistat—type 2 diabetes mellitus	0.000187	0.000723	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000186	0.000723	CcSEcCtD
Adefovir Dipivoxil—Headache—Orlistat—type 2 diabetes mellitus	0.000185	0.000719	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000185	0.000716	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000183	0.000709	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000182	0.000706	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000181	0.0007	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000179	0.000695	CcSEcCtD
Adefovir Dipivoxil—Nausea—Valsartan—type 2 diabetes mellitus	0.000178	0.00069	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000176	0.000683	CcSEcCtD
Adefovir Dipivoxil—Nausea—Orlistat—type 2 diabetes mellitus	0.000176	0.000681	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Losartan—type 2 diabetes mellitus	0.000174	0.000674	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Metformin—type 2 diabetes mellitus	0.000173	0.000672	CcSEcCtD
Adefovir Dipivoxil—Rash—Metformin—type 2 diabetes mellitus	0.000172	0.000667	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000172	0.000666	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Losartan—type 2 diabetes mellitus	0.000171	0.000664	CcSEcCtD
Adefovir Dipivoxil—Headache—Metformin—type 2 diabetes mellitus	0.000171	0.000662	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00017	0.000658	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000166	0.000642	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000164	0.000636	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000164	0.000636	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000164	0.000634	CcSEcCtD
Adefovir Dipivoxil—Rash—Irbesartan—type 2 diabetes mellitus	0.000162	0.000629	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000162	0.000628	CcSEcCtD
Adefovir Dipivoxil—Nausea—Metformin—type 2 diabetes mellitus	0.000162	0.000628	CcSEcCtD
Adefovir Dipivoxil—Headache—Irbesartan—type 2 diabetes mellitus	0.000161	0.000625	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Losartan—type 2 diabetes mellitus	0.000154	0.000597	CcSEcCtD
Adefovir Dipivoxil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000153	0.000593	CcSEcCtD
Adefovir Dipivoxil—Rash—Losartan—type 2 diabetes mellitus	0.000153	0.000592	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000153	0.000591	CcSEcCtD
Adefovir Dipivoxil—Headache—Losartan—type 2 diabetes mellitus	0.000152	0.000588	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Ramipril—type 2 diabetes mellitus	0.000149	0.000578	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000147	0.00057	CcSEcCtD
Adefovir Dipivoxil—Nausea—Losartan—type 2 diabetes mellitus	0.000144	0.000558	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000142	0.000551	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Ramipril—type 2 diabetes mellitus	0.000132	0.000512	CcSEcCtD
Adefovir Dipivoxil—Rash—Ramipril—type 2 diabetes mellitus	0.000131	0.000508	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000131	0.000507	CcSEcCtD
Adefovir Dipivoxil—Headache—Ramipril—type 2 diabetes mellitus	0.00013	0.000504	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ramipril—type 2 diabetes mellitus	0.000123	0.000478	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GNB3—type 2 diabetes mellitus	4.7e-05	0.000346	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—APOA1—type 2 diabetes mellitus	4.68e-05	0.000344	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—type 2 diabetes mellitus	4.68e-05	0.000344	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—HMOX1—type 2 diabetes mellitus	4.68e-05	0.000344	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—COX2—type 2 diabetes mellitus	4.66e-05	0.000343	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC5A2—type 2 diabetes mellitus	4.66e-05	0.000343	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTR—type 2 diabetes mellitus	4.64e-05	0.000341	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CAT—type 2 diabetes mellitus	4.62e-05	0.00034	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.61e-05	0.000339	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA6—type 2 diabetes mellitus	4.58e-05	0.000336	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALDOB—type 2 diabetes mellitus	4.57e-05	0.000336	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NAMPT—type 2 diabetes mellitus	4.55e-05	0.000335	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.55e-05	0.000334	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.55e-05	0.000334	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GCK—type 2 diabetes mellitus	4.53e-05	0.000333	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—UCP3—type 2 diabetes mellitus	4.5e-05	0.000331	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—UCP2—type 2 diabetes mellitus	4.5e-05	0.000331	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSD11B1—type 2 diabetes mellitus	4.5e-05	0.000331	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IAPP—type 2 diabetes mellitus	4.5e-05	0.000331	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SOD1—type 2 diabetes mellitus	4.49e-05	0.00033	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOB—type 2 diabetes mellitus	4.49e-05	0.00033	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—type 2 diabetes mellitus	4.44e-05	0.000326	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC9A1—type 2 diabetes mellitus	4.42e-05	0.000325	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—type 2 diabetes mellitus	4.36e-05	0.000321	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.36e-05	0.000321	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.36e-05	0.000321	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.35e-05	0.00032	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GNB3—type 2 diabetes mellitus	4.34e-05	0.000319	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.33e-05	0.000318	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.29e-05	0.000315	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—LPL—type 2 diabetes mellitus	4.28e-05	0.000315	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF2—type 2 diabetes mellitus	4.27e-05	0.000314	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GLP1R—type 2 diabetes mellitus	4.25e-05	0.000313	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PCK1—type 2 diabetes mellitus	4.23e-05	0.000311	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ADCY5—type 2 diabetes mellitus	4.19e-05	0.000308	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-05	0.000307	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.15e-05	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.15e-05	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—APOB—type 2 diabetes mellitus	4.14e-05	0.000304	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HMGA1—type 2 diabetes mellitus	4.14e-05	0.000304	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPARG—type 2 diabetes mellitus	4.13e-05	0.000303	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.09e-05	0.000301	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CD36—type 2 diabetes mellitus	4.07e-05	0.000299	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SNAP25—type 2 diabetes mellitus	4.06e-05	0.000298	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSMD6—type 2 diabetes mellitus	4.06e-05	0.000298	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—INS—type 2 diabetes mellitus	4.05e-05	0.000297	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-05	0.000295	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A2—type 2 diabetes mellitus	3.97e-05	0.000292	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HK1—type 2 diabetes mellitus	3.96e-05	0.000291	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.96e-05	0.000291	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CYBA—type 2 diabetes mellitus	3.93e-05	0.000289	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.92e-05	0.000288	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.9e-05	0.000287	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CPT1A—type 2 diabetes mellitus	3.89e-05	0.000286	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTR—type 2 diabetes mellitus	3.89e-05	0.000286	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.88e-05	0.000285	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.87e-05	0.000284	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-05	0.000283	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.85e-05	0.000283	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—KCNJ11—type 2 diabetes mellitus	3.83e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSD3B2—type 2 diabetes mellitus	3.83e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—LPA—type 2 diabetes mellitus	3.83e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCKR—type 2 diabetes mellitus	3.83e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NAMPT—type 2 diabetes mellitus	3.81e-05	0.00028	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALCA—type 2 diabetes mellitus	3.8e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.8e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—LIPC—type 2 diabetes mellitus	3.79e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HBA1—type 2 diabetes mellitus	3.79e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GCK—type 2 diabetes mellitus	3.79e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARA—type 2 diabetes mellitus	3.78e-05	0.000278	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP11A1—type 2 diabetes mellitus	3.77e-05	0.000277	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.76e-05	0.000276	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CD36—type 2 diabetes mellitus	3.76e-05	0.000276	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.74e-05	0.000275	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.74e-05	0.000275	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—type 2 diabetes mellitus	3.71e-05	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PPP2CA—type 2 diabetes mellitus	3.71e-05	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.71e-05	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC9A1—type 2 diabetes mellitus	3.7e-05	0.000272	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A1—type 2 diabetes mellitus	3.67e-05	0.00027	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDOB—type 2 diabetes mellitus	3.67e-05	0.00027	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AGT—type 2 diabetes mellitus	3.66e-05	0.000269	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CETP—type 2 diabetes mellitus	3.66e-05	0.000269	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS1—type 2 diabetes mellitus	3.62e-05	0.000266	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CALM1—type 2 diabetes mellitus	3.6e-05	0.000265	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOE—type 2 diabetes mellitus	3.59e-05	0.000264	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.59e-05	0.000264	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TCF7L2—type 2 diabetes mellitus	3.58e-05	0.000263	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	3.56e-05	0.000262	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.55e-05	0.000261	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NOS3—type 2 diabetes mellitus	3.55e-05	0.000261	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-05	0.000261	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A4—type 2 diabetes mellitus	3.52e-05	0.000259	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.5e-05	0.000257	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.5e-05	0.000257	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	3.47e-05	0.000255	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MMP1—type 2 diabetes mellitus	3.43e-05	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GLP1R—type 2 diabetes mellitus	3.41e-05	0.000251	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSMD6—type 2 diabetes mellitus	3.4e-05	0.00025	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SNAP25—type 2 diabetes mellitus	3.4e-05	0.00025	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SREBF1—type 2 diabetes mellitus	3.4e-05	0.00025	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.35e-05	0.000246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CTGF—type 2 diabetes mellitus	3.34e-05	0.000245	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CALM1—type 2 diabetes mellitus	3.33e-05	0.000244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMGCR—type 2 diabetes mellitus	3.31e-05	0.000243	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.28e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—APOA1—type 2 diabetes mellitus	3.28e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.27e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.26e-05	0.000239	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—type 2 diabetes mellitus	3.25e-05	0.000239	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.24e-05	0.000238	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADRA2A—type 2 diabetes mellitus	3.24e-05	0.000238	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.23e-05	0.000237	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	3.19e-05	0.000234	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A2—type 2 diabetes mellitus	3.18e-05	0.000234	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.15e-05	0.000232	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-05	0.00023	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PRKCB—type 2 diabetes mellitus	3.13e-05	0.00023	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.12e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CPT1A—type 2 diabetes mellitus	3.12e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTR—type 2 diabetes mellitus	3.12e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2E1—type 2 diabetes mellitus	3.11e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS2—type 2 diabetes mellitus	3.09e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A1—type 2 diabetes mellitus	3.07e-05	0.000226	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A2—type 2 diabetes mellitus	3.07e-05	0.000226	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—INS—type 2 diabetes mellitus	3.07e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR2—type 2 diabetes mellitus	3.06e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NAMPT—type 2 diabetes mellitus	3.06e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCK—type 2 diabetes mellitus	3.04e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—LIPC—type 2 diabetes mellitus	3.04e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HBA1—type 2 diabetes mellitus	3.04e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.02e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP11A1—type 2 diabetes mellitus	3.02e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP3A4—type 2 diabetes mellitus	3e-05	0.00022	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC9A1—type 2 diabetes mellitus	2.97e-05	0.000218	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN2B—type 2 diabetes mellitus	2.97e-05	0.000218	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.96e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GCG—type 2 diabetes mellitus	2.95e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A4—type 2 diabetes mellitus	2.95e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CETP—type 2 diabetes mellitus	2.93e-05	0.000216	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.92e-05	0.000214	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOB—type 2 diabetes mellitus	2.89e-05	0.000213	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.84e-05	0.000208	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—type 2 diabetes mellitus	2.81e-05	0.000207	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LPL—type 2 diabetes mellitus	2.76e-05	0.000203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF1—type 2 diabetes mellitus	2.74e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT2—type 2 diabetes mellitus	2.74e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SNAP25—type 2 diabetes mellitus	2.73e-05	0.0002	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSMD6—type 2 diabetes mellitus	2.73e-05	0.0002	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SREBF1—type 2 diabetes mellitus	2.73e-05	0.0002	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ADCY5—type 2 diabetes mellitus	2.7e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CTGF—type 2 diabetes mellitus	2.68e-05	0.000197	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMGCR—type 2 diabetes mellitus	2.65e-05	0.000195	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.63e-05	0.000193	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.6e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.6e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—type 2 diabetes mellitus	2.6e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADRA2A—type 2 diabetes mellitus	2.6e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP2CA—type 2 diabetes mellitus	2.59e-05	0.00019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CCR5—type 2 diabetes mellitus	2.54e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.54e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GNB3—type 2 diabetes mellitus	2.54e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMOX1—type 2 diabetes mellitus	2.53e-05	0.000186	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CAT—type 2 diabetes mellitus	2.5e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2E1—type 2 diabetes mellitus	2.49e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—type 2 diabetes mellitus	2.49e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.48e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS3—type 2 diabetes mellitus	2.48e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.47e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A2—type 2 diabetes mellitus	2.47e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A1—type 2 diabetes mellitus	2.47e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOB—type 2 diabetes mellitus	2.42e-05	0.000178	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP3A4—type 2 diabetes mellitus	2.4e-05	0.000177	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—type 2 diabetes mellitus	2.37e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IRS2—type 2 diabetes mellitus	2.37e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCG—type 2 diabetes mellitus	2.36e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A4—type 2 diabetes mellitus	2.36e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—type 2 diabetes mellitus	2.36e-05	0.000173	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-05	0.000173	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.34e-05	0.000172	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALM1—type 2 diabetes mellitus	2.32e-05	0.000171	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOE—type 2 diabetes mellitus	2.32e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—LPL—type 2 diabetes mellitus	2.31e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOA1—type 2 diabetes mellitus	2.29e-05	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADCY5—type 2 diabetes mellitus	2.26e-05	0.000166	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX1—type 2 diabetes mellitus	2.26e-05	0.000166	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.25e-05	0.000165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	2.21e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CD36—type 2 diabetes mellitus	2.2e-05	0.000162	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.17e-05	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS2—type 2 diabetes mellitus	2.16e-05	0.000159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-05	0.000153	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IRS1—type 2 diabetes mellitus	2.07e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARA—type 2 diabetes mellitus	2.04e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.04e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNB3—type 2 diabetes mellitus	2.04e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMOX1—type 2 diabetes mellitus	2.03e-05	0.000149	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CAT—type 2 diabetes mellitus	2e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AGT—type 2 diabetes mellitus	1.98e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—INS—type 2 diabetes mellitus	1.98e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.96e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-05	0.000143	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOB—type 2 diabetes mellitus	1.94e-05	0.000143	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOE—type 2 diabetes mellitus	1.94e-05	0.000143	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT2—type 2 diabetes mellitus	1.91e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—type 2 diabetes mellitus	1.89e-05	0.000139	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—LPL—type 2 diabetes mellitus	1.86e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SRC—type 2 diabetes mellitus	1.84e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SERPINE1—type 2 diabetes mellitus	1.82e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADCY5—type 2 diabetes mellitus	1.82e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX1—type 2 diabetes mellitus	1.81e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—type 2 diabetes mellitus	1.79e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CD36—type 2 diabetes mellitus	1.76e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.74e-05	0.000128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3R1—type 2 diabetes mellitus	1.73e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS3—type 2 diabetes mellitus	1.73e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-05	0.000124	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—type 2 diabetes mellitus	1.67e-05	0.000123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—INS—type 2 diabetes mellitus	1.66e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—type 2 diabetes mellitus	1.64e-05	0.000121	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARA—type 2 diabetes mellitus	1.64e-05	0.00012	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-05	0.00012	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AGT—type 2 diabetes mellitus	1.59e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—type 2 diabetes mellitus	1.59e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CALM1—type 2 diabetes mellitus	1.56e-05	0.000115	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOE—type 2 diabetes mellitus	1.56e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOA1—type 2 diabetes mellitus	1.54e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—type 2 diabetes mellitus	1.52e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-05	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-05	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARG—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-05	9.76e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—INS—type 2 diabetes mellitus	1.33e-05	9.76e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SRC—type 2 diabetes mellitus	1.28e-05	9.43e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-05	9.09e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—type 2 diabetes mellitus	1.22e-05	8.95e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.17e-05	8.56e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NOS3—type 2 diabetes mellitus	1.17e-05	8.56e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—type 2 diabetes mellitus	1.15e-05	8.43e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	1.14e-05	8.39e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—type 2 diabetes mellitus	1.12e-05	8.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—type 2 diabetes mellitus	1.07e-05	7.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—type 2 diabetes mellitus	8.64e-06	6.35e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—type 2 diabetes mellitus	7.97e-06	5.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—type 2 diabetes mellitus	6.68e-06	4.91e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	5.36e-06	3.94e-05	CbGpPWpGaD
